Edwards Lifesciences (EW) Assets Average (2010 - 2026)

Edwards Lifesciences has reported Assets Average for 17 years, with the latest figure at $13.6 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 2.55% year-over-year to $13.6 billion in Q2 2026; TTM through Jun 2026 was $13.6 billion, a 2.55% increase from a year earlier, with the FY2025 full-year figure at $13.4 billion, up 19.33% from the prior year.
• Assets Average was $13.6 billion for Q2 2026 at Edwards Lifesciences, up from $13.5 billion in the prior quarter.
• The five-year high for Assets Average was $13.6 billion in Q2 2026, with the low at $8.4 billion in Q2 2022.
• Average Assets Average over 5 years is $10.8 billion, with a median of $9.7 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average increased 0.13% in 2023, then jumped 38.93% in 2024.
• Over 5 years, Assets Average stood at $8.5 billion in 2022, then climbed by 10.65% to $9.4 billion in 2023, then surged by 38.93% to $13.0 billion in 2024, then climbed by 3.62% to $13.5 billion in 2025, then climbed by 0.81% to $13.6 billion in 2026.
• The last three Assets Average figures came in at $13.6 billion (Q2 2026), $13.5 billion (Q1 2026), and $13.5 billion (Q4 2025), per Business Quant data.